A U.S. humanitarian waiver will allow people in several countries to continue accessing life-saving HIV treatments, the UNAIDS said on Wednesday, after President Donald Trump's freeze on foreign aid threatened such supplies.

The World Health Organisation (WHO) has expressed deep concern about the funding pause for HIV programmes in low- and middle-income countries.

The Trump administration has moved to stop the supply of lifesaving drugs for HIV, malaria, and tuberculosis in countries supported by USAID around the globe.

As part of the foreign aid freeze by President Donald Trump, the U.S. distribution of HIV drugs in poor countries has been stopped.

A stop in all of PEPFAR’s work shuttered clinics this week. Then, a new exemption for “life-saving” treatment left organizations uncertain.

The President’s Emergency Plan for AIDS Relief (PEPFAR), a federal program that provides HIV medications, is one of the programs on pause during a 90-day review ordered by the Secretary of State.

The World Health Organization (WHO) expresses deep concern on the implications of the immediate funding pause for HIV programmes in low- and middle-income countries.

Almost 1 in 10 patients receiving HIV care may have binge eating disorder (BED), a significantly higher rate than the 0.3% reported in the general population, according to a cross-sectional study. Individuals with possible BED were six times more likely than others to have clinical obesity and twice as likely to be overweight.

An outbreak of the infectious lung disease TB in Kansas is one of the largest ever recorded in the US. What is TB, and why have cases risen since the COVID-19 pandemic?

PEPFAR partners describe a whiplash-inducing stop-work order, which has left them with many questions — including whether they can continue to provide lifesaving treatment — but very few answers.

Let’s have fun by starting with trading De’Aaron Fox.